The GERD Device Market: At the Crossroads & What’s Next for the GERD Device Market: A Conversation with Skip Baldino by Mary Thompson
Complete this form to download your free copy:
The GERD Device Market: At the Crossroads by Mary Thompson
After years of struggle and a long list of technology and company failures, minimally invasive devices designed to treat chronic gastroesophageal reflux disease may finally be seeing some light at the end of the tunnel. New Category I CPT codes, as well as widespread reports linking chronic use of acid-reducing drugs to a number of severe maladies, are creating some tailwinds for device players in this field—but payors remain skeptical, and only companies with compelling clinical evidence are likely to fully benefit.
What’s Next for the GERD Device Market: A Conversation with Skip Baldino by Mary Thompson
To learn more about how current market dynamics might impact the GERD device arena going forward, and how EndoGastric Solutions plans to tackle the challenges ahead, we recently spoke at length with EGS CEO Skip Baldino.